Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
CMPS
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LONDON & NEW YORK, October 02, 2026--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equ…
COMPASS Pathways (CMPS) Could Be 49% Below Fair Value Following Its Phase III Progress
COMPASS Pathways (CMPS) is back in focus after recent share price swings, with the mental health biotech drawing attention as investors reassess its psilocybin-based COMP360 pipeline and current valuation. Recent trading tells a mixed stor…
Compass Pathways Appoints Kelley Boucher as Chief People Officer
LONDON & NEW YORK, September 30, 2026--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced the appointment of Kelley Bo…
Key Points Interested in Cybin Inc.? Here are five stocks we like better. Cybin, doing business as Helus Pharma, asked shareholders to approve changing the corporate name to Helus Pharma Inc. and setting the board at eight directors; both…
Compass Pathways to Participate in TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026
LONDON & NEW YORK, September 16, 2026--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will a…
Strata Mental Health Solutions Awarded U.S. Healthcare Provider Training Grant from Compass Pathways to Develop Provider Training for COMP360
Strata's implementation platform includes provider training, certification, site readiness, and ongoing clinical support; its founders worked with Compass on the COMP360 training program for clinicians, who supported and monitored particip…
Compass Pathways to Participate in Investor Conferences the Week of September 14th
LONDON & NEW YORK, September 10, 2026--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will p…
Wall Street slips for a third straight day as oil and yields climb
4:20pm: Treasury yields climb Wall Street extended its selloff on Wednesday, with the Dow Jones Industrial Average falling 440 points as oil prices topped $100 a barrel and Treasury yields climbed to their highest levels in nearly three ye…
FDA names acting heads of drug and vaccine units to permanent roles
[FDA Headquarters] The Trump administration on Tuesday appointed the acting heads of the FDA units overseeing drugs, vaccines, and tobacco to permanent positions weeks after nominating White House advisor Heidi Overton as the agency's next…
Compass Pathways to Debut U.S. HCP Education Campaign and Present New HEOR Data at Psych Congress 2026
Compass will debut Change the Tune in TRD, a new U.S. healthcare provider (HCP) education campaign for treatment-resistant depression (TRD) at Booth #901 Seven poster presentations include new health economics and outcomes research (HEOR)…
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LONDON & NEW YORK, September 03, 2026--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted e…
Compass Pathways Recognized as a 2026 Fierce 50 Breakthrough Honoree
LONDON & NEW YORK, September 02, 2026--(BUSINESS WIRE)--Compass Pathways, a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, has been named a 2026 Fierce 50 Breakthrough honoree by F…
Compass Pathways to Participate in 2026 Cantor Global Healthcare Conference on September 9, 2026
LONDON & NEW YORK, September 01, 2026--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will a…
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Canopy Growth Posted 13% Revenue Growth as Losses Narrowed Sharply in Q1 FY2027 Aurora Cannabis Narrowed Q1 Loss as International Medical Cannabis Growth Gained Ground Cronos Group Reported Record Q2 Revenue…
Compass Pathways to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026
LONDON & NEW YORK, August 06, 2026--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will atte…
Compass Pathways Working with U.S. Department of Veterans Affairs for Investigational Study of Psilocybin
LONDON & NEW YORK, August 06, 2026--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today it is working with the U.…
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LONDON & NEW YORK, August 05, 2026--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equi…
Compass Pathways PLC (CMPS) (Q2 2026) Earnings Call Highlights: Strong Cash Position and NDA ...
This article first appeared on GuruFocus. Cash Position: $433 million in cash on hand as of June 30, 2026, expected to fund operations through launch and into 2028. Regulatory Milestone: Rolling NDA submission for COMP360 in treatment-resi…
Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
Data from two positive Phase 3 trials demonstrated rapid onset of effect and durable benefit through at least 6 months, further validating COMP360's potential to establish a new standard of care in TRD COMP360 has a highly differentiated c…
Here are the major earnings before the open Wednesday
Major earnings expected before the bell on Wednesday include: * The Walt Disney Company (DIS [https://seekingalpha.com/symbol/DIS]) * Eli Lilly and Company (LLY [https://seekingalpha.com/symbol/LLY]) * Shopify (SHOP [https://seekingalpha.c…
Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026
Compass Management will host a conference call at 8:00 am ET (1:00 pm UK) LONDON & NEW YORK, July 29, 2026--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment…
Eli Lilly Is Acquiring AtaiBeckley for $2.8 Billion. Cathie Wood Thinks Another Psychedelic Drug Stock Is an Even Better Bet.
The psychedelic medicine field looks like it's finally about to take off, and that's catching the attention of portfolio managers like Cathie Wood. Eli Lilly (NYSE: LLY) agreed on July 16 to acquire the biotech AtaiBeckley (NASDAQ: ATAI) f…
Cathie Wood’s ARK Invest’s largest purchase during July 20-24 was Tesla (TSLA [https://seekingalpha.com/symbol/TSLA]), with the firm acquiring an additional $52.7M stake after a steep sell-off post weaker-than-expected Q2 earnings report.…
5 Stocks That Created Fortunes: CMPS +327%, ARWR +222%, CGON +148%, DRTS +182%, ELMD +86%
(RTTNews) - "If you aren't willing to own a stock for 10 years, don't even think about owning it for 10 minutes." - Warren Buffett. The Oracle of Omaha's timeless advice reminds us that patience is one of the key principles of investing. T…
Cathie Wood makes $20.5M bet on sliding tech stock
SpaceX (SPCX) investors are reeling after a brutal sell-off. The stock has comfortably slipped below its $135 IPO price, according to Yahoo Finance, facing concerns over Starship delays, an incredibly rich valuation, and a major post-earni…
Psychedelic Therapy Meets M&A: Fireside Chat with Jupiter Neurosciences CEO Christer Rosén & President Alison Silva
Watch Fireside Chat Below, or Click HERE: IPO Edge hosted a fireside chat with Jupiter Neurosciences, Inc. (Nasdaq: JUNS) Chairman, Chief Executive Officer and Co-founder Christer Rosén and Alison Silva, President and Chief Operations Offi…
Notable healthcare headlines for the week: UnitedHealth, J&J, and Intuitive Surgical in focus
Wall Street's major averages ended lower on Friday as global technology stocks declined, led by semiconductors and the debut of Moonshot AI's Kimi-K3, which dragged down investor sentiment. The benchmark S&P 500 fell 1%, while the tech-hea…
Cathie Wood buys $36.1 million of tumbling tech stock
Cathie Wood, CEO of Ark Investment Management, is known for buying high-growth stocks soon after they go public, especially when share prices pull back after an early rally. That's exactly what she's doing with SpaceX this week, adding mor…
Stock Market Today, July 16: AtaiBeckley Surges on Eli Lilly Acquisition Worth Up To $3.8 Billion
AtaiBeckley (NASDAQ:ATAI), a clinical-stage mental health and psychedelic drug developer, closed at $7.15, up 33.4%. Eli Lilly's (NYSE:LLY) announced acquisition drove the move, and investors are watching the deal terms and closing process…
Investing.com -- Shares of psychedelic drug developers are surging premarket on Thursday after Eli Lilly announced a definitive agreement to acquire AtaiBeckley Inc., validating the sector and lifting sentiment across the space. AtaiBeckle…
[Wall Street New York City] aluxum/E+ via Getty Images Here's a quick look at the stocks that are seeing gap-up moves before the bell Thursday. Stock index futures fell on Thursday, with Nasdaq futures leading declines amid weakness in glo…
Is COMPASS Pathways plc (CMPS) Stock a Psychedelic Medicine Opportunity After Positive COMP360 Data?
We recently compiled a list of the 7 Best Psychedelic Stocks to Buy According to Analysts. COMPASS Pathways plc (NASDAQ:CMPS) is one of the best psychedelic stocks on our list. TheFly reported on July 7 that Oppenheimer reaffirmed its Outp…
The Race to Commercialize the World’s Most Powerful Psychedelic
An obscure psychedelic is drawing intense interest from the pharmaceutical industry. WSJ explores why companies are betting hundreds of millions of dollars on the therapeutic potential of a toad poison. View Comments
Psychedelic drugmakers could get boost from HHS, VA memorandum
[Psychedelic Brain Therapy] wildpixel/iStock via Getty Images * A memorandum of understanding brokered Monday between HHS and the Veterans Administration could bode well for companies developing psychedelic-based drug treatments. * The MOU…
Cathie Wood reshuffles portfolio ahead of Q2, buys SpaceX, Eli Lilly, Meta; pares AMD, Roku
Cathie Wood's ARK Invest's largest purchase during the last week by value was Elon Musk's Space Exploration Technologies (SPCX [https://seekingalpha.com/symbol/SPCX]), adding a combined 349K shares across ARKK, ARKQ, ARKW and ARKX for ~$52…
This article first appeared on GuruFocus. Cathie Wood's ARK added to its Meta Platforms (NASDAQ:META) position while further reducing its stake in Advanced Micro Devices (NASDAQ:AMD), according to the firm's daily trade disclosure released…